|
[1]REHERMANN B,BERTOLETTI A.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections[J].Hepatology,2015,61(2):712-721.
|
|
[2]ASADULLAH K,STERRY W,VOLK HD.Interleukin-10 therapyreview of a new approach[J].Pharmacol Rev,2003,55(2):241-269.
|
|
[3]NI G,WANG T,WALTON S,et al.Manipulating IL-10 signalling blockade for better immunotherapy[J].Cell Immunol,2015,293(2):126-129.
|
|
[4]SARAIVA M,O'GARRA A.The regulation of IL-10 production by immune cells[J].Nate Rev Immunol,2010,10(3):170-181.
|
|
[5]NG CT,OLDSTONE MB.IL-10:achieving balance during persistent viral infection[J].Curr Top Microbiol Immunol,2014,380:129-144.
|
|
[6]GABRYSOVA L,HOWES A,SARAIVA M,et al.The regulation of IL-10 expression[J].Curr Top Microbiol Immunol,2014,380:157-190.
|
|
[7]D'ANDREA A,ASTE-AMEZAGA M,VALIANTE NM,et al.Interleukin 10(IL-10)inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells[J].J Exp Med,1993,178(3):1041-1048.
|
|
[8]MANNINO MH,ZHU Z,XIAO H,et al.The paradoxical role of IL-10 in immunity and cancer[J].Cancer Lett,2015,367(2):103-107.
|
|
[9]SAXENA A,KHOSRAVIANI S,NOEL S,et al.Interleukin-10paradox:a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy[J].Cytokine,2015,74(1):27-34.
|
|
[10]LUNEMANN S,MALONE DF,HENGST J,et al.Compromised function of natural killer cells in acute and chronic viral hepatitis[J].J Infect Dis,2014,209(9):1362-1373.
|
|
[11]MAINI MK,PEPPA D.NK cells:a double-edged sword in chronic hepatitis B virus infection[J].Front Immunol,2013,4:57.
|
|
[12]WU SF,WANG WJ,GAO YQ.Natural killer cells in hepatitis Bvirus infection[J].Braz J Infect Dis,2015,19(4):417-425.
|
|
[13]BRYCESON YT,CHIANG SC,DARMANIN S,et al.Molecular mechanisms of natural killer cell activation[J].J Innate Immun,2011,3(3):216-226.
|
|
[14]PROTZER U,MAINI MK,KNOLLE PA.Living in the liver:hepatic infections[J].Nat Rev Immunol,2012,12(3):201-213.
|
|
[15]LANG PA,LANG KS,XU HC,et al.Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+T-cell immunity[J].Proc Natl Acad Sci U S A,2012,109(4):1210-1215.
|
|
[16]JI HW.Effect of NK cells in the hepatitis B virus infection[J].China Med Herald,2014,11(34):161-165.(in Chinese)姬恒伟.NK细胞在乙型肝炎病毒感染中作用[J].中国医药导报,2014,11(34):161-165.
|
|
[17]DUNN C,PEPPA D,KHANNA P,et al.Temporal analysis of early immune responses in patients with acute hepatitis B virus infection[J].Gastroenterology,2009,137(4):1289-1300.
|
|
[18]PEPPA D,MICCO L,JAVAID A,et al.Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection[J].PLoS Pathog,2010,6(12):e1001227.
|
|
[19]HYODO N,NAKAMURA I,IMAWARI M.Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection[J].Clin Exp Immunol,2004,135(3):462-466.
|
|
[20]SU R,XIONG YL,LIU Y,et al.Characteristics of regulatory Bcells and serum IL-10,IP-10 in different immune phases of chronic hepatitis B virus infection[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition,2015,9(4):468-473.(in Chinese)苏然,熊亚莉,刘勇,等.不同免疫状态下慢性HBV感染者外周血调节性B细胞及血清IL-10和IP-10的表达特点[J/CD].中华实验和临床感染病杂志:电子版,2015,9(4):468-473.
|
|
[21]DAS A,ELLIS G,PALLANT C,et al.IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection[J].J Immunol,2012,189(8):3925-3935.
|
|
[22]WEBSTER G J,REIGNAT S,MAINI MK,et al.Incubation phase of acute hepatitis B in man:dynamic of cellular immune mechanisms[J].Hepatology,2000,32(5):1117-1124.
|
|
[23]FISICARO P,VALDATTA C,BONI C,et al.Early kinetics of innate and adaptive immune responses during hepatitis B virus infection[J].Gut,2009,58(7):974-982.
|
|
[24]JU Y,HOU N,MENG J,et al.T cell immunoglobulin-and mucin-domain-containing molecule-3(Tim-3)mediates natural killer cell suppression in chronic hepatitis B[J].J Hepatol,2010,52(3):322-329.
|
|
[25]ZHANG Z,ZHANG S,ZOU Z,et al.Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients[J].Hepatology,2011,53(1):73-85.
|
|
[26]TJWA ET,van OORD GW,HEGMANS JP,et al.Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B[J].J Hepatol,2011,54(2):209-218.
|
|
[27]TU Z,BOZORGZADEH A,PIERCE RH,et al.TLR-dependent cross talk between human Kupffer cells and NK cells[J].J Exp Med,2008,205(1):233-244.
|
|
[28]LASSEN MG,LUKENS JR,DOLINA JS,et al.Intrahepatic IL-10 maintains NKG2A+Ly49-liver NK cells in a functionally hyporesponsive state[J].J Immunol,2010,184(5):2693-2701.
|
|
[29]KAKIMI K,GUIDOTTI LG,KOEZUKA Y,et al.Natural killer Tcell activation inhibits hepatitis B virus replication in vivo[J].JExp Med,2000,192(7):921-930.
|
|
[30]GUIDOTTI LG,ROCHFORD R,CHUNG J,et al.Viral clearance without destruction of infected cells during acute HBV infection[J].Science,1999,284(5415):825-829.
|
|
[31]TREPO C,CHAN HL,LOK A.Hepatitis B virus infection[J].Lancet,2014,384(9959):2053-2063.
|
|
[32]MICCO L,PEPPA D,LOGGI E,et al.Differential boosting of innate and adaptive antiviral responses during pegylated-interferonalpha therapy of chronic hepatitis B[J].J Hepatol,2013,58(2):225-233.
|
|
[33]MAHDAVI M,AMIRRASOULI H,ALAVIAN SM,et al.Impact of pegylated interferon-alfa-2a on perforin level in patients with chronic hepatitis B;preliminary study[J].Hepat Mon,2013,13(11):e11903.
|
|
[34]MAINI MK,GEHRING AJ.The role of innate immunity in the immunopathology and treatment of HBV infection[J].J Hepatol,2016,64(1 Suppl):s60-s70.
|
DownLoad: